Berghammer Anthony, Adams Joella W, Khan Sazid, Bobashev Georgiy
RTI International Research Triangle Park, 3040 East Cornwallis Road P.O. Box 12194, NC 27709-2194, United States.
Drug Alcohol Depend Rep. 2024 Jul 17;12:100262. doi: 10.1016/j.dadr.2024.100262. eCollection 2024 Sep.
Expanding Medicaid plays a large role in ensuring that people across the United States have access to health care services. Although North Carolina recently moved toward Medicaid expansion, the impact of expansion on overdoses and overdose mortality may vary based on the type of treatment (offering medications for opioid use disorder [MOUD] vs. offering inpatient medically managed withdrawal without linkage to further MOUD treatment or non-MOUD-based treatment) accessed by individuals newly eligible for treatment through expansion. Based on official North Carolina statistics and published peer-reviewed literature, we developed a simulation model that forecasts opioid overdose and mortality under different scenarios for type of treatment accessed (MOUD-based vs. non-MOUD-based) and Medicaid coverage levels. An optimistic scenario assuming 70 % of individuals newly eligible for treatment would enter treatment during the first year of expansion estimated that 332 (Simulation Interval: 246-412) overdose deaths would be averted. A scenario more in line with recent historical trends assuming 38 % of individuals newly eligible for treatment would enter treatment resulted in 213 (Simulation Interval: 157-263) averted overdose deaths. In all scenarios, MOUD-based treatment approaches increased the number of lives saved compared with approaches expanding opioid treatment through non-MOUD-based treatment. Our study emphasized the need to ensure access to MOUD-based treatment for individuals newly covered by the Medicaid expansion.
扩大医疗补助计划在确保美国各地民众能够获得医疗服务方面发挥着重要作用。尽管北卡罗来纳州最近朝着扩大医疗补助计划的方向迈进,但扩大计划对药物过量及药物过量死亡率的影响可能因新符合条件通过扩大计划接受治疗的个人所获得的治疗类型(提供阿片类药物使用障碍药物治疗[MOUD]与提供住院医疗管理的戒断治疗但不与进一步的MOUD治疗或非基于MOUD的治疗相联系)而有所不同。基于北卡罗来纳州的官方统计数据和已发表的同行评审文献,我们开发了一个模拟模型,该模型预测在不同的治疗类型(基于MOUD与非基于MOUD)和医疗补助覆盖水平的情况下阿片类药物过量及死亡率。一个乐观的情景假设70%新符合治疗条件的个人将在扩大计划的第一年进入治疗,估计可避免332例(模拟区间:246 - 412)药物过量死亡。一个更符合近期历史趋势的情景假设38%新符合治疗条件的个人将进入治疗,结果可避免213例(模拟区间:157 - 263)药物过量死亡。在所有情景中,与通过非基于MOUD的治疗扩大阿片类药物治疗的方法相比,基于MOUD的治疗方法挽救的生命数量更多。我们的研究强调了确保新纳入医疗补助扩大计划覆盖范围的个人能够获得基于MOUD的治疗的必要性。